Showing 571-580 of 7442 results for "".
Expanding the Field: A New Botulinum Neurotoxin A Enters The US Arena
https://practicaldermatology.com/topics/general-topics/PD0609_07-php/22816/A cosmetic dermatologist with experience using Dysport describes how clinicians may approach the new agent in practice.Journal Club: Atopic Dermatitis Control Tool
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-atopic-dermatitis-control-tool/26734/Peter Lio, MD, talks with Lisa Swanson, MD, a board-certified dermatologist and pediatric dermatologist practicing in Boise, Idaho, about the Atopic Dermatitis Control Tool (ADCT). Highlighted in a recent study published in the British Journal of Dermatology, the ADCT has been said to provide patienJournal Club: Oral JAK Inhibitors in Moderate-to-Severe AD
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-oral-jak-inhibitors-moderate-severe-ad/24539/Peter Lio, MD, talks with Robert Sidbury, MD, MPH, a dermatologist at Seattle Children's Hospital, about nuanced differences in guideline-recommended use of oral JAK inhibitors in pediatric patients with moderate-to-severe atopic dermatitis (AD) provided in the Annals of Allergy, Asthma, and ImmunolDermWire TV: Factors Affecting Long-term Antibiotic Prescriptions for Acne; Biologics Firm Focusing on Plaque Psoriasis Makes an Important Acquisition; Practical Dermatology Launches Two New Video Series
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-factors-affecting-long-term-antibiotic-prescriptions-acne-biologics-firm-focusing-plaque-psoriasis-makes-important-acquisition-practical-dermatology-launches-two-new-video-series/24319/In this episode of DermWire TV, a new analysis highlights factors affecting long-term antibiotic prescriptions for acne; a company developing plaque psoriasis biologics makes a major acquisition; and Practical Dermatology® launches two new video series focusing on advancing treatment and improving uLet’s Talk About Truncal Acne
https://practicaldermatology.com/topics/acne-rosacea/lets-talk-about-truncal-acne/23785/A look at the burden of truncal acne and current treatment options.Aesthetic Dermatology in 2021
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aesthetic-dermatology-in-2021/23468/A look at how the COVID-19 pandemic has affected the demand for aesthetic procedures in dermatology offices around the country.DermWireTV: Qwo Approved, Assessing Resident Anxiety
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-qwo-approved-assessing-resident-anxiety/19830/FDA has approved Qwo (collagenase clostridium histolyticum-aaes) from Endo, the first injectable treatment approved for moderate to severe cellulite in the buttocks of adult women. A recent survey offers perspective on anxiety among third-year dermatology residents in light of the COVID crisis. AlleDermWireTV: Practices Reopen; Prescriber's Choice Expands; Sun Takes on Acne
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-practices-reopen-prescribers-choice-expands-sun-takes-on-acne/19810/Dermatology practices across the US are re-opening and professional associations are offering guidance, as states reduce restrictions. From Prescriber's Choice comes PC Direct for in-office use and PC Delivers for remote prescribing. Sun Dermatology’s Take on Acne advertising campaign is raising awaUpdate on Isotretinoin, Depression, and Suicide: Appropriate Monitoring is Key
https://practicaldermatology.com/topics/general-topics/update-on-isotretinoin-depression-and-suicide-appropriate-monitoring-is-key/21859/Data have failed to show a direct relationship between isotretinoin use and depression or suicide, but the cumulative evidence suggests patients with severe acne require careful monitoring.Pediatric, Acne, and AD Sessions: Dr. Eichenfield
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/pediatric-acne-and-ad-sessions-dr-eichenfield/32684/Lawrence Eichenfield, MD, discusses his presentations from Maui Derm 2025, which included "Pediatric Dermatology 2025," "Update 2025: Acne and Rosacea," and "Atopic Dermatitis and Pruritus: Current Concepts and Therapeutics for 2025." Highlights include the importance of recognizing severe and rapid